Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline in Newly Diagnosed Hodgkin Lymphoma
NCT05490953Phase 4Unknown
- Sponsor
- Universidad de Guadalajara
- Start
- Jul 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pentoxifylline in Hodgkin lymphoma (HL), sponsored by Universidad de Guadalajara. Status: unknown.
02
Drugs
pentoxifylline
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT05490953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05490953.